financetom
Business
financetom
/
Business
/
PetVivo, ThinkEquity Terminate At-The-Market Offering Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PetVivo, ThinkEquity Terminate At-The-Market Offering Deal
Mar 11, 2024 9:24 AM

12:00 PM EDT, 03/11/2024 (MT Newswires) -- PetVivo Holdings ( PETV ) said in a Monday filing that the company and ThinkEquity mutually agreed to terminate their at-the-market sales agreement dated August 2023 for the sale of up to $2.5 million of common stock.

The company said it issued and sold 674,000 shares of its common stock under the agreement for net proceeds of $959,033 before termination.

Shares of PetVivo ( PETV ) were nearly 1% higher in recent trading.

Price: 1.05, Change: -0.02, Percent Change: -1.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Meta Platforms Adds Parental Controls for AI Characters
Meta Platforms Adds Parental Controls for AI Characters
Oct 17, 2025
08:28 AM EDT, 10/17/2025 (MT Newswires) -- Meta Platforms ( META ) said Friday that it is providing simple, new ways for parents to control how much interaction their children have with artificial intelligence characters. The company said the new features will allow parents to block their kids' access to one-on-one chats with AI characters entirely, or just block specific...
Summit Therapeutics Expands Phase III Ivonescimab Program Into Colorectal Cancer
Summit Therapeutics Expands Phase III Ivonescimab Program Into Colorectal Cancer
Oct 17, 2025
08:29 AM EDT, 10/17/2025 (MT Newswires) -- Summit Therapeutics ( SMMT ) said Friday it is initiating a phase III trial to evaluate bispecific antibody ivonescimab as a first line therapy in patients with unresectable metastatic colorectal cancer. The biopharmaceutical company said the trial represents a first global study of ivonescimab beyond non-small cell lung cancer. The phase III trial...
Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters AI-Driven Digital Ecosystem
Taoping Signs Letter of Intent to Acquire Alphalion Holding, Significantly Bolsters AI-Driven Digital Ecosystem
Oct 17, 2025
SHENZHEN, China, Oct. 17, 2025 /PRNewswire/ -- Taoping Inc. ( TAOP ) , a provider of innovative smart cloud platform services and solutions, today announced that it has entered into a non-binding Letter of Intent (LOI) with the shareholders of Alphalion Holding Limited (Alphalion Holding) to acquire 100% of its equity interests. The proposed acquisition remains subject to the completion...
Erayak Unveils New Innovation Hub Nexora Group, Stock Gains
Erayak Unveils New Innovation Hub Nexora Group, Stock Gains
Oct 17, 2025
Erayak Power Solution Group Inc. ( RAYA ) shares traded higher Friday after the company announced the launch of its U.S.-based subsidiary, Nexora Group Inc. The subsidiary will serve as its North American headquarters and a key pillar in its international expansion strategy. Nexora will coordinate sales, marketing, logistics, and localized product development for the U.S. and Canadian markets. Also...
Copyright 2023-2026 - www.financetom.com All Rights Reserved